Analysts’ Recent Ratings Updates for Aveanna Healthcare (AVAH)

Aveanna Healthcare (NASDAQ: AVAH) has recently received a number of price target changes and ratings updates:

• 3/23/2026 – Aveanna Healthcare had its price target lowered by Royal Bank Of Canada from $11.00 to $9.00. They now have a “sector perform” rating on the stock.
• 3/20/2026 – Aveanna Healthcare was upgraded by Weiss Ratings from “hold (c)” to “buy (b-)”.
• 3/20/2026 – Aveanna Healthcare had its price target lowered by BMO Capital Markets from $11.00 to $10.00. They now have an “outperform” rating on the stock.
• 3/20/2026 – Aveanna Healthcare had its price target lowered by Truist Financial Corporation from $10.00 to $9.00. They now have a “hold” rating on the stock.
• 3/20/2026 – Aveanna Healthcare was upgraded by Raymond James Financial, Inc. from “outperform” to “strong-buy”. They now have a $13.00 price target on the stock.
• 3/12/2026 – Aveanna Healthcare was given a new $10.00 price target by Truist Financial Corporation.
• 2/3/2026 – Aveanna Healthcare was downgraded by Zacks Research from “strong-buy” to “hold”.

Insiders Place Their Bets

In other Aveanna Healthcare news, CEO Jeff Shaner sold 173,225 shares of the stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total value of $1,248,952.25. Following the completion of the sale, the chief executive officer owned 2,650,892 shares of the company’s stock, valued at $19,112,931.32. This trade represents a 6.13% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, insider Patrick A. Cunningham sold 18,436 shares of Aveanna Healthcare stock in a transaction that occurred on Thursday, February 19th. The shares were sold at an average price of $7.21, for a total transaction of $132,923.56. Following the sale, the insider owned 337,755 shares in the company, valued at $2,435,213.55. This represents a 5.18% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 998,595 shares of company stock worth $7,567,770 in the last 90 days. 7.00% of the stock is owned by company insiders.

Aveanna Healthcare, Inc (NASDAQ: AVAH) is a national provider of in-home health care services, specializing in pediatric skilled nursing, therapy, and related support for medically complex and chronically ill children. The company delivers a range of clinical and therapeutic solutions designed to enable patients to receive care in the comfort of their own homes, reducing the need for hospital stays and long-term institutional care. Aveanna’s offerings include registered nursing, physical, occupational and speech therapy, behavioral health counseling, and durable medical equipment coordination.

In addition to pediatric home health services, Aveanna operates adult home health and personal care support programs, assisting elderly and disabled adults with daily living activities, medication management, and rehabilitation therapies.